Effectiveness of a web-based education program to improve vaccine storage conditions in primary care (Keep Cool): study protocol for a randomized controlled trial by Anika Thielmann et al.
TRIALS
Thielmann et al. Trials  (2015) 16:301 
DOI 10.1186/s13063-015-0824-9STUDY PROTOCOL Open AccessEffectiveness of a web-based education
program to improve vaccine storage conditions
in primary care (Keep Cool): study protocol for a
randomized controlled trial
Anika Thielmann, Anja Viehmann and Birgitta M. Weltermann*Abstract
Background: Immunization programs are among the most effective public health strategies worldwide. Adequate
vaccine storage is a prerequisite to assure the vaccines’ effectiveness and safety. In a questionnaire survey among a
random sample of German primary care physicians, we discovered vaccine storage deficits: 16 % of physicians had
experience with cold chain breaches either as an error or near error, 49 % did not keep a temperature log, and
21 % did not use a separate refrigerator for vaccine storage. In a recent feasibility study of 21 practice refrigerators,
we showed that these were outside the target range 10.2 % of the total time with some single refrigerators being
outside the target range as much as 66.3 % of the time. These cooling-chain deficits are consistent with the
international medical literature, yet an effective, easy to disseminate, practice-centered intervention to improve
storage conditions is lacking.
Methods/design: This randomized intervention trial will be conducted in a random sample of primary care practices.
Based on continuous temperature recordings over 7 days, all practices with readings outside the target range for
vaccine storage (+2 °C to +8 °C) will be randomly allocated to a web-based education program or a waiting list control
group. The practice physicians and their teams constitute the target population. Participants will be educated about
best practices in vaccine storage and will receive a manual including storage checklists and templates for temperature
documentation. In all practices, temperatures of the vaccine refrigerators will be monitored continuously using a data
logger with a glycol probe as a surrogate for vaccine vial temperature. The effectiveness of the web-based education
program will be determined after 6 months in terms of the proportion of refrigerators with vaccine vial temperatures
within the target range (+2 °C to +8 °C) during 7-day temperature logging. Secondary outcome parameters include
temperature monitoring, no critically low temperatures (≤ -0.5 °C), compliance with storage recommendations,
knowledge of good vaccine storage conditions, and assignment of personnel as vaccine storage manager and backup.
Discussion: Keep Cool will develop and evaluate a web-based education program to improve vaccine storage
conditions in primary care and thereby ensure immunization safety and effectiveness.
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Immunizations are among the most effective and cost-
effective public health strategies worldwide [1]. Ad-
equate vaccine storage is a prerequisite to maintain ef-
fectiveness and safety of the vaccines. The maintenance
of the vaccine cold chain (2 °C to 8 °C) is of utmost im-
portance to assure vaccine potency [2]. Detailed analyses
of vaccine temperature sensitivities documented freezing
of vaccines as being more critical than heating, at
least in our moderate Western European climate.
Modern adsorbed hepatitis B vaccines were docu-
mented to be the most sensitive vaccines with a freezing
point of -0.5 °C [2]. At this temperature, irreversible pre-
cipitates of aluminum-containing adsorbents begin to
form, which decrease the potency and can induce local
irritation upon injection [2, 3].
In a cross-sectional web-based questionnaire survey,
we analyzed vaccination management among a 10 % ran-
dom sample of primary care physicians from one of Ger-
many’s largest federal states, North Rhine-Westphalia [4]
using international recommendations for vaccine storage
[5–9]. The survey (n = 211) revealed that 16 % of the
primary care physicians have experience with cold chain
breaches either as an error or near error; 8 % do not
regularly control their storage with regard to vaccine
wrapping, vaccine expiration date, and refrigerator
temperature; 49 % do not keep a storage temperature
log; and 21 % fail to use a separate refrigerator solely for
vaccine storage. In a recent feasibility study, we ob-
served that the correct temperature range of 2 to 8 °C
was not consistently maintained in seven of 21 (33.3 %)
vaccine refrigerators from teaching practices. Refrigera-
tors were outside the target range 10.2 % of the total
time, with single refrigerators outside the target range
for as much as 66.3 % of the time. These results are in
line with studies worldwide, which discuss the following
key problems related to vaccine storage: 1) temperatures
outside the target range [10, 11], 2) lack of adequate
temperature measurement devices [12–14], 3) lack of
continuous temperature documentation [4, 12–14], 4) use
of inadequate refrigerators [9, 10, 12], 5) lack of separ-
ate refrigerators [13–15], 6) inadequate storage prac-
tices [2, 12, 14, 15], 7) lack of designated personnel
[14], and 8) insufficient staff training and guidance
[12, 14, 16–18].
Prior studies addressing these deficits used the following
intervention components either alone or in combination:
1) written educational materials, 2) introduction of ther-
mometers with or without feedback on temperature read-
ings by either graphic display or telephone advice to
personnel, and 3) 1:1 onsite education with inspection of
refrigerators. In 2002, a prospective intervention study of
721 US primary care practices achieved improved compli-
ance with several storage recommendations of up to 19 %after 3 months following the distribution of a manual, a
thermometer and a feedback checklist [12]. Similar results
with improvements ranging from 13 to 23 % after 4 weeks
were shown in a Korean study of 39 private clinics, which
provided onsite 1:1 education including the distribution of
a manual. This study also documented improved aware-
ness of various vaccine storage criteria ranging from 3 %
to 29 % [16]. With regard to reaching the targeted
temperature range, the best result was observed in an
Australian study of 50 primary care practices: onsite edu-
cation and the distribution of min/max-thermometers led
to a fourfold increase of practices with refrigerator tem-
peratures in the target range [18]. The two studies avail-
able, which provided long-term follow-ups after 6 months,
1 year, and 5 years, documented a tendency for improved
temperatures in the populations studied but also reported
fluctuations over time in 25 % of the practices with ini-
tially optimal temperatures [19, 20]. The repetitive docu-
mentation of such fluctuations in intervention as well as
control groups underlines the need for structural change
as part of educational interventions, including the long-
term implementation of practice routines for daily
temperature monitoring.
Following recommendations on effectively changing
medical practice [21], our study will use a complex ap-
proach focusing on the individual as well as the
organizational level by encouraging structural changes.
The intervention will address both professional groups
involved in the management of vaccines, that is, the
physician managers in charge, as well as the practice as-
sistants who handle vaccines. Based on didactic ap-
proaches such as information tailoring and confidence-
based learning, relevant information will be presented in
a web-based education program, which tailors infor-
mation to each users’ knowledge. Prospectively, this
e-learning approach will allow for widespread dissem-
ination at low cost.
Keep Cool aims to evaluate the effectiveness of a web-
based education program to improve vaccine storage
conditions in primary care practices. The main outcome
used to determine the effectiveness of the intervention is
the proportion of refrigerators with vaccine vials within
the target range (+2 °C to +8 °C) during 7-day monitor-
ing after 6 months.
Methods/design
Study design
Keep Cool is a prospective, randomized, controlled
intervention trial, which will be performed in a random
sample of primary care practices (see Fig. 1). After tele-
phone recruitment, all practices will be visited by a study
assistant to set up temperature data loggers (t0). Based
on continuous temperature recordings over 7 days, all
practices with readings outside the target range for
Fig. 1 Study overview
Thielmann et al. Trials  (2015) 16:301 Page 3 of 8vaccine storage (+2 °C to +8 °C) will be randomly allo-
cated (1:1) to an intervention group or a waiting list
control group. Practices with temperatures within the
target range will be followed separately to monitor
temperature fluctuations. Baseline data on knowledge
will be collected at t1 prior to the start of the interven-
tion, whereas the compliance with storage recommenda-
tions and the assignment of personnel as vaccine storage
manager and backup will have already been documented
by the study assistant during recruitment (t0). After
baseline measurements at t1, the intervention group will
receive access to the e-learning program. Follow-up data
will be obtained after 6 months (t2) and, to study the in-
tervention’s long-term effectiveness, after 1 year (t3) and
18 months (t4). After the intervention phase is com-
pleted, the waiting list control group will receive access
to the e-learning program.
Ethical approval was obtained from the Ethic
Commission of the Medical Faculty of the UniversityHospital Essen, University of Duisburg-Essen (reference
number: 14-6118-BO, date of approval: 04/02/2015). Keep
Cool follows the Ethical Principles of the World Medical
Association Declaration of Helsinki (WMA 1964).Study population
The target population of this randomized controlled trial
is primary care physicians and their practice personnel.
The majority of these personnel completed a 3-year vo-
cational training with a degree (practice assistants). A
few practices also employ secretaries, nurses or
personnel without a degree, but with on-the-job training.
The intervention will address all staff members handling
vaccines regardless of their prior training. Practices are
eligible if they administer vaccinations and are situated
within a 50-km radius of Essen, Germany. All participat-
ing physicians and practice personnel will sign an in-
formed consent form.
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Physicians and practice personnel will participate in a
web-based education program on the storage of vac-
cines according to international best practices (for ex-
ample, WHO and CDC). To ensure the target
populations’ acceptance of the program, we will ask
primary care physicians and practice assistants of aca-
demic teaching practices of our research network to
join recurrent focus group sessions. This group will
facilitate the development, adaptation, implementa-
tion, and evaluation phase of the intervention.
The e-learning program will be developed using a
teaching software that allows the tailoring of informa-
tion to each user group (that is, physicians and med-
ical assistants) and each individual’s previous response
behavior. Following confidence-based learning, the e-
learning program will require participants to a) an-
swer concrete vaccine storage-related questions and
b) indicate the degree to which they feel confident in
the correctness of each answer. Depending on the re-
spondents’ answers, that is, correctness and confi-
dence of answers, each participant will receive
learning input with subsequent learning-success-
adjusted repetitions of questions to achieve optimal
memorizing effects. All participants will receive tai-
lored feedback during the course of answering ques-
tions on an item level and for all items after
completion of the program.
Five educational topics will be addressed by the web-
based education program:
1. Requirements for technical equipment including
refrigerator criteria; types of thermometers;
equipment maintenance.
2. Vaccine temperature sensitivity, target temperature,
and daily reviewing and recording of temperatures:
freezing thresholds of freeze-sensitive vaccines;
refrigerator target range (2-8 °C = 35.6-46.4 °F);
necessity of daily recording; recording criteria; need
for long-term temperature logs; and use of data logs
(paper-based or electronically).
3. Principles of vaccine storage inside a refrigerator
including the preparation of refrigerators for
vaccine storage, background knowledge about the
use of domestic refrigerators for vaccine storage
(incl. refrigerator cycles, temperature zones),
necessity of a separate refrigerator for the sole
purpose of vaccine storage, standards for vaccine
storage within refrigerators, and use of storage
aids.
4. Vaccine cold chain-related processes including
vaccine arrival procedures, periodic manual storage
control, and procedures for dealing with cold chain
breaches and equipment failure.5. Responsibilities of practice personnel including the
assignment of personnel as vaccine storage manager
and backup.
To facilitate long-term changes at the organizational
level, all practices will be advised to assure the following
two structural components: 1) the assignment of
personnel as vaccine storage manager and at least one
backup and 2) the set-up of a comprehensive
temperature monitoring system. This includes reviewing
temperatures using a standard thermometer, recording
temperatures in a temperature log, taking immediate ac-
tion if needed, and retaining temperature logs. In
addition to a storage manual summarizing the program
content, the following material will be made available as
a web download: a “temperature log template,” guides
for “preparing a refrigerator for vaccine storage,” “stor-
ing vaccines in the refrigerator,” “refrigerator mainten-
ance,” plans for “routine vaccine management,” and
“emergency response,” as well as a summarizing over-
view of the “tasks of the vaccine coordinator.”
Outcomes
Primary outcome: The proportion of refrigerators with
vaccine vials within the target range (+2 °C to +8 °C)
during a 7-day monitoring at 5-minute intervals after 6
months. Temperature inside the target range is chosen
as the primary outcome, because it is of utmost import-
ance that nonfreezing vaccines are stored in this
temperature range. When absorbed mono- and combin-
ation vaccines reach their individual freezing thresholds,
their chemical structures irreversibly change. This can
lead to increased local reactions and reduced effective-
ness. The most sensitive vaccines are hepatitis B vac-
cines with a freezing threshold of -0.5 °C [2]. A thermal
analysis of frequently used types of refrigerators by the
US Department of Commerce [22, 23] showed that vac-
cine vial temperatures vary depending on the refrigerator
type, loading density and location of vaccines inside the
refrigerator. Typical refrigerators used in German pri-
mary care are the types “freezerless” (single refrigerator
compartment without a freezer) and “dual zone” (separ-
ate compartments for refrigerator and freezer, both with
individual doors), both so-called domestic refrigerators.
Based on different scenarios, that is, door openings and
loading density, temperatures can vary by +/-2.3 °C in
the type “freezerless” and by +/-4.5 °C in the type “dual
zone” [22, 23]. The maintenance of the temperature
range of +2 to +8 °C, as recommended by vaccine manu-
facturers and public health authorities worldwide, is
hence justified and therefore serves as a primary out-
come measure.
Temperatures will be measured via a data logger that
is approved by the US Center for Disease Control
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practice in order to ensure consistency of temperature
readings across locations. Continuous measurements
over 7 days are planned for baseline (t0) and continu-
ously thereafter, with follow-ups after 6 months (t2), 1
year (t3) and 18 months (t4). Continuous measurements
are preferable to single-point measurements because
many practices use nonpurpose built refrigerators (so-
called domestic refrigerators). Such refrigerators are
known to have temperature cycles that result from their
on-/off-construction: using the physical principle of the
Carnot cycle, they cool down to a specific temperature,
after which the cooling department is shut off until a
higher temperature is reached [22, 23]. To analyze such
temperature fluctuations, we chose a logging interval of
one reading every 5 minutes. Similar logging rates were
used in prior studies [12, 14, 17, 19, 20]. The logging
period of 7 days ensures that at least one regular work-
ing week and one weekend are included. This takes
differences in patient flow and refrigerator door open-
ings into account (for example, typically more
patients on Mondays).
Secondary outcomes follow international best practices
and guidelines:
1. Temperature monitoring - Improvement in
temperature monitoring with optimal monitoring
defined as electronic or paper-based recording
with a minimum of two readings per day for
the previous 5.5 months (5 % missing entries
allowed). Prior studies indicated that temperature
fluctuations without adequate adjustments over
time are a main barrier to intervention success.
To overcome this barrier, this intervention program
will emphasize temperature monitoring, including
temperature reviewing, recording, taking immediate
action if needed and retention of temperature
logs.
2. Refrigerators not freezing - The proportion of
practices with vaccine vials not reaching critically
low temperatures (-0.5 °C or lower) will be
determined.
3. Compliance with storage recommendations -
Improvement in actual refrigerator-related storage
quality will be assessed at practice level according to
the following examples:a. Refrigerator is used exclusively for vaccine
storage.
b. Standard thermometer is located in refrigerator.
c. No vaccines are stored in refrigerator door.
d. Vaccines are stored in their original wrapping.
e. e Vaccines are stored in the center of the
refrigerator.f. Use of a stock management system (for example,
“earliest expiry first out (EEFO)” principle) and
regular manual stock control.4. Knowledge about vaccine storage - Improvement in
knowledge of good vaccine storage conditions in
physicians and practice personnel will be studied
using a standardized questionnaire.
5. Assignment of personnel - During the initial practice
visit the study assistant will ask if practices currently
have assigned personnel as vaccine storage manager
and backup. This is considered an important
structural characteristic to maintain long-term
changes at practice level.
Measurement instruments
Temperature data logging
An important distinguishing factor from previous
studies, but in line with international best practices
[5–7], is the use of a data logger with one high-
accuracy thermistor probe immersed in glycol. In
contrast to a standard air probe, the slow-reacting
glycol probe resembles the temperature changes of
the vaccine vials, whereas the fast-reacting air probe
only shows the ambient air temperatures inside the
refrigerator and the effects of door openings on re-
frigerator temperatures.
Specifications and set-up of the chosen data logger are
described below:
1. Type - EL-GFX-DTP.
2. Manufacturer - Lascar Electronics Ltd, UK.
3. Probe - High-accuracy thermistor probe immersed
in glycol.
4. Accuracy for probe within the operating range -5 °C
to +10 °C - +/− 0.1 °C.
5. Logging rate - 1 reading per 5 minutes.
According to standards, this data logger will be
placed in the center of the refrigerator for continu-
ous recording. In practices using more than one re-
frigerator for vaccine storage, the refrigerator most
frequently used and closest to the reception desk will
be selected.
Self-administered questionnaire (knowledge and
temperature monitoring)
The questionnaire will consist of a knowledge part
(part 1) and a part addressing current structures and
procedures used for monitoring of temperatures (part
2). The knowledge part will be developed drawing on
the international body of recognized best practices
and guidelines (for example, WHO), official checklists
used in other countries (UK, US, and AUS) and
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Items will correspond to the five educational topics
detailed above. In addition, sociodemographic charac-
teristics of physician and practice personnel (sex, age,
years in practice/job, part-/full-time, and job content)
and practice characteristics (single/group, number of
physicians/medical assistants in practice, number of
patients quarterly, average number of vaccinations
daily, age structure of patients, and urban/rural) will
be included. In part two, the current structures and
procedures used for the monitoring of temperatures
will be obtained. Participants will complete part 1 and
2 of the questionnaire after accessing the web-based
program, but before starting with the educational pro-
gram itself (t1). Follow-up measurements will use a
paper-based version of part 1 of the questionnaire,
handed out and collected when downloading follow-
up data logger readings (t2 and t4). Inspections of
temperature logbooks at t2 and t4 will serve as the
follow-up measurement for part 2.
Storage checklist
Changes in the compliance with storage recommenda-
tions will be assessed using a checklist completed by the
study assistant. This checklist will be a modification of a
tool used in the previously mentioned intervention study
by Lee et al. (2012) [16] and draws on the same sources
listed above. This checklist is completed when the data
loggers are set up (t0) and again when the temperature
readings are downloaded (t2, t3, t4).
Waiting list control group The control group will con-
sist of practices that have temperature readings outside
the target range during baseline data collection. The
control group will be monitored via a temperature data
logger but will receive access to the e-learning program
only after t2. By including a control group, an interven-
tion bias due to the set-up of data loggers is taken into
account. The control group is closest to regular everyday
care and serves as a baseline to better determine the ef-
fectiveness of the intervention.
Safety issues
All practices will be informed in detail about their vac-
cine refrigerator temperature. The tailored education
and the download material will address the issue of how
to deal with temperature breaches. Practices with
temperature readings outside the target range will re-
ceive additional information after t2. The following
safety regulations will be followed:
1. Practices with any temperature beyond the target
range will receive detailed information on the date
and duration of the incident.2. They will also receive detailed information
recommending that the manufacturer’s hotline(s) be
contacted for information on how to deal with
vaccines exposed to inadequate temperatures, and if
additional vaccinations of patients are required to
assure patient immunity.
3. In addition, practices will receive the contact data of
the Paul Ehrlich Institute, the Federal German




The study will be performed in a random sample of pri-
mary care practices in North Rhine-Westphalia,
Germany. The sample will be restricted to practices
within a 50-km radius of the University Hospital Essen.
To support a systematic recruitment process and ensure
detailed documentation of all contact attempts and com-
munications with the practices, we will use a response-
tracking database. To achieve a high response rate, we
will follow a multi-level approach, consisting of up to
three invitation letters and up to five phone calls on dif-
ferent days and at different times. The first phone call
with each physician is to ensure the eligibility of prac-
tice, that is, vaccines are administered, provide add-
itional study information, schedule an appointment for
the first practice visit by the study assistant. In order to
allow for a nonparticipant analysis, practices refusing
participation will be asked to complete a short question-
naire on their practice characteristics (solo/group prac-
tice, number of patients quarterly, number of physicians
in practice, number of refrigerators used, and availability
of a refrigerator thermometer).
Randomization
Based on results of the temperature baseline data collec-
tion, practices with temperatures outside the target
range will be randomized equally to the two study arms
(1:1). The randomization procedure is computer-based
through www.random.org. No participant will be in-
formed about the study hypotheses in detail.
Sample size estimation
The intervention study will be performed in a sample of
46 primary care practices (23 practices per arm) with
suboptimal temperature readings at baseline during a 7-
day monitoring period (t0). A sample size of 23 practices
per group provides an 80 % power to detect anticipated
differences between the groups at a significance level of
0.05 %. We assume that 70 % of the practices in the
intervention group will reach the temperature target
range at follow-up. This assumption is based on two inter-
vention studies of comparable intensity that observed
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suboptimal practices, using continuous temperature read-
ings as the outcome [18, 19]. Regarding the control group,
we expect that 30 % of practices will reach the
temperature target range at follow-up due to a study par-
ticipation effect because of being exposed to temperature
monitoring via data logger. This assumption is based on
an intervention study that observed optimal temperature
readings in 33 % of the control group at follow-up [18].
Owing to the lack of intervention studies available, the
power calculation is based on more conservative
assumptions.
As the intervention will only be conducted in practices
with suboptimal temperatures, a total of 174 practices
will have to be recruited for t0. This is based on the as-
sumption that 33.3 % of refrigerators will be outside the
target range (n = 58). This percentage is derived from
the abovementioned prospective feasibility study in 17
primary care practices with 21 vaccine refrigerators and
similar results reported by Bell et al. (2001), Jeremijenko
et al. (1996) and Lewis et al. (2001) [14, 18, 20]. Our cal-
culation takes into account a dropout rate of 20 %. This
dropout rate is based on our experience and corresponds
to reports from other cluster-randomized trials [24].
Using an adaptive design, baseline temperature measure-
ments for t0 will be stopped as soon as the anticipated
total sample of n = 58 is reached.
Statistical analysis
Descriptive statistics will be used to describe baseline
characteristics for both study arms with regard to prac-
tice characteristics (single/group, number of physicians/
medical assistants in practice, number of patients quar-
terly, average number of vaccinations daily/per week,
age structure of patients), participating physician and
practice personnel characteristics (sex, age, years in
practice/job, part-time/full-time, job content). The ef-
fectiveness will be assessed by comparing the interven-
tion and control group and by intragroup comparison
(baseline versus follow-up). We will evaluate the effect-
iveness based on temperature as the main outcome
(within range yes/no) by comparing both groups using
the chi-square test. For intergroup analyses, all dichot-
omous secondary outcomes will be evaluated using chi-
square tests for each item. In addition, compliance with
storage recommendations will be analyzed on the basis
of a sum score calculated across all items by using a t-
test. For in-group comparisons, McNemar tests will be
calculated for dichotomous outcomes and t-tests for
dependent samples for sum scores. Temperature moni-
toring will be measured on an ordinal level to allow for
application of the Mann-Whitney U Test (intergroup
comparison) and the Wilcoxon signed rank sum test
(intragroup comparison). A P value <0.05 will beconsidered significant. All statistical analyses will be per-
formed using IBM SPSS 22® on Windows.
Discussion
To our knowledge, this will be the first randomized con-
trolled trial evaluating a web-based approach in com-
parison to a control group addressing the issue of
vaccine storage. The topic is important to ensure vaccine
effectiveness and safety but currently plays a minor role,
at least in German primary care practices. Some of this
lack of recognition is due to the fact that this topic is
only marginally addressed, if addressed at all, in the
medical education of physicians and practice personnel.
Effectively changing medical practice requires a “com-
plex approach focused on different levels, tailored to
specific settings and target groups” [21]. To address the
issue of vaccine storage, we chose a web-based educa-
tion that combines a number of benefits. First, while be-
ing as effective and satisfactory as traditional educational
approaches [25, 26], it addresses both target populations,
that is, physicians and practice team members. The
tailored presentation of relevant learning content is dis-
cussed to increase the appropriateness of the informa-
tion on a personal level, thereby implying that contents
are better remembered and more frequently discussed
(for example, [27]). Although computer tailoring has not
been studied in healthcare providers, it was proven to be
effective in patients’ health education and promotion
[28, 29]. Second, an e-learning intervention tool can eas-
ily be used for recurrent training, for example, to train
new personnel in case of fluctuation or to retrain staff in
the form of continuous medical education. Third, in
contrast to 1:1 education our web-based learning format
can be disseminated on a larger scale at low cost.
Methodologically, the study exhibits a number of
strengths. First, in contrast to prior studies, continuous
vial temperature using a glycol probe as opposed to
single-point measurements of ambient air temperature is
used as a primary outcome parameter. Second, to take
into account the frequently reported fluctuations in per-
formances, several strategies to intensify the intervention
are combined: the intervention is directed at both the in-
dividual physician and practice personnel as well as the
organizational level. Participants will receive tailored in-
formation and a manual for later reference, whereas the
practice as an organizational unit will receive managerial
support in the form of templates, plans and guides for
various aspects of vaccine management, for example, for
temperature recording and emergency plans in the event
of equipment failure. A manual on vaccine storage man-
agement is a novelty to German practices as currently
no agreed-upon reference is available, and the official
German recommendations for vaccines contain only lit-
tle information on storage issues. Third, in contrast to
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of intervention contents and implementation processes,
we will describe the content of the web-based education
intervention in detail to allow for replication and/or
building on research findings. Fourth, our web-based
intervention is designed for future widespread use in
small and larger healthcare institutions at low cost.
Trial status
Practice recruitment is planned to start in January 2016.
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